{"id":"https://openalex.org/W2114294642","doi":"https://doi.org/10.2174/138161211797249189","title":"The Role of Integrins in Glioma Biology and Anti-Glioma Therapies","display_name":"The Role of Integrins in Glioma Biology and Anti-Glioma Therapies","publication_year":2011,"publication_date":"2011-08-01","ids":{"openalex":"https://openalex.org/W2114294642","doi":"https://doi.org/10.2174/138161211797249189","mag":"2114294642","pmid":"https://pubmed.ncbi.nlm.nih.gov/21827415"},"language":"en","primary_location":{"id":"doi:10.2174/138161211797249189","doi":"https://doi.org/10.2174/138161211797249189","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161211797249189","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091648075","display_name":"Ghazaleh Tabatabai","orcid":"https://orcid.org/0000-0002-3542-8782","observed_orcids":["https://orcid.org/0000-0002-3542-8782"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ghazaleh Tabatabai","raw_affiliation_strings":["Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland. ghazaleh.tabatabai@usz.ch","Dept. of Neurology, University Hospital Z\u00fcrich, Frauenklinikstrasse 26, 8091 Z\u00fcrich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland. ghazaleh.tabatabai@usz.ch","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"Dept. of Neurology, University Hospital Z\u00fcrich, Frauenklinikstrasse 26, 8091 Z\u00fcrich, Switzerland","institution_ids":["https://openalex.org/I4210100468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113821223","display_name":"J\u00f6rg\u2010Christian Tonn","orcid":"https://orcid.org/0009-0004-1756-423X","observed_orcids":["https://orcid.org/0009-0004-1756-423X"]},"institutions":[{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jorg-Christian Tonn","raw_affiliation_strings":["Ludwig-Maximilian University of Munich"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig-Maximilian University of Munich","institution_ids":["https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053052330","display_name":"Roger Stupp","orcid":"https://orcid.org/0000-0002-5483-3118","observed_orcids":["https://orcid.org/0000-0002-5483-3118"]},"institutions":[{"id":"https://openalex.org/I2802229882","display_name":"Centre Hospitalier Universitaire Vaudois","ror":"https://ror.org/05a353079","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2802229882"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Roger Stupp","raw_affiliation_strings":["Centre Hospitalier Universitaire Vaudois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire Vaudois","institution_ids":["https://openalex.org/I2802229882"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017177249","display_name":"Michael Weller","orcid":"https://orcid.org/0000-0002-1748-174X","observed_orcids":["https://orcid.org/0000-0002-1748-174X"]},"institutions":[{"id":"https://openalex.org/I4210100468","display_name":"University Hospital Zurich","ror":"https://ror.org/01462r250","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210100468"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Michael Weller","raw_affiliation_strings":["Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.,Switzerland","University Hospital Z\u00fcrich"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.,Switzerland","institution_ids":["https://openalex.org/I4210100468"]},{"raw_affiliation_string":"University Hospital Z\u00fcrich","institution_ids":["https://openalex.org/I4210100468"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.4579,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.89729144,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"17","issue":"23","first_page":"2402","last_page":"2410"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/integrins","display_name":"integrins","score":0.9940000176429749},{"id":"https://openalex.org/keywords/glioma","display_name":"glioma","score":0.9629999995231628},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/cilengitide","display_name":"cilengitide","score":0.9079999923706055},{"id":"https://openalex.org/keywords/rgd-peptide","display_name":"RGD peptide","score":0.6809999942779541},{"id":"https://openalex.org/keywords/integrin-inhibition","display_name":"integrin inhibition","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8389999866485596},{"id":"https://openalex.org/keywords/tumor-cell-migration-and-invasion","display_name":"tumor cell migration and invasion","score":0.8190000057220459},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/cancer-stem-cells","display_name":"cancer stem cells","score":0.7990000247955322},{"id":"https://openalex.org/keywords/mgmt-promoter-methylation","display_name":"MGMT promoter methylation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/alkylating-chemotherapy","display_name":"alkylating chemotherapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.8799999952316284},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.902999997138977},{"id":"https://openalex.org/keywords/anti-integrin-therapy","display_name":"anti-integrin therapy","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.8725953102111816},{"id":"https://openalex.org/C195687474","wikidata":"https://www.wikidata.org/wiki/Q409715","display_name":"Integrin","level":3,"score":0.6537938117980957},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4552347958087921},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4526526629924774},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.4484710991382599},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3392874002456665},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18287542462348938},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10870444774627686}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016023","descriptor_name":"Integrins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016023","descriptor_name":"Integrins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016212","descriptor_name":"Transforming Growth Factor beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D060833","descriptor_name":"Cellular Microenvironment","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2174/138161211797249189","doi":"https://doi.org/10.2174/138161211797249189","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161211797249189","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:21827415","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21827415","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unil.ch:iris/230614","doi":null,"is_oa":false,"landing_page_url":"https://iris.unil.ch/handle/iris/230614","pdf_url":null,"source":{"id":"https://openalex.org/S7407055444","display_name":"IRIS","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"review article"},{"id":"pmh:oai:serval.unil.ch:BIB_E90BAF906A3F","doi":null,"is_oa":false,"landing_page_url":"https://serval.unil.ch/notice/serval:BIB_E90BAF906A3F","pdf_url":null,"source":{"id":"https://openalex.org/S4306401797","display_name":"SERVAL (Universit\u00e9 de Lausanne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210093590","host_organization_name":"Swiss School of Archaeology in Greece","host_organization_lineage":["https://openalex.org/I4210093590"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Current Pharmaceutical Design, vol. 17, no. 23, pp. 2402-2410","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/63035","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/63035","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Tabatabai, G., Tonn, J. C., Stupp, R., & Weller, M. (2011). The role of integrins in glioma biology and anti-glioma therapies. Current Pharmaceutical Design, 17, 2402\u20132410. https://doi.org/10.2174/138161211797249189","raw_type":"Journal Article"},{"id":"pmh:oai:www.zora.uzh.ch:50515","doi":null,"is_oa":false,"landing_page_url":"https://www.zora.uzh.ch/50515","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Tabatabai, G; Tonn, J C; Stupp, R; Weller, M (2011). The role of integrins in glioma biology and anti-glioma therapies. Current Pharmaceutical Design, 17(23):2402-2410.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2029763637","https://openalex.org/W1900328322","https://openalex.org/W2097387635","https://openalex.org/W2157053069","https://openalex.org/W1974778790","https://openalex.org/W2248413224","https://openalex.org/W2103816610","https://openalex.org/W2124795444","https://openalex.org/W2147000598","https://openalex.org/W2603381469"],"abstract_inverted_index":{"The":[0],"tumor":[1,6,23,40],"environment":[2],"is":[3,84],"critical":[4],"for":[5,208],"maintenance":[7],"and":[8,28,39,48,71,81,112,121,211],"progression.":[9],"Integrins":[10],"are":[11],"a":[12,75,97,175,201,216],"large":[13],"family":[14],"of":[15,22,63,79,123,126,178,215,219],"cell":[16,42],"surface":[17],"receptors":[18],"mediating":[19],"the":[20,61,124,127,213],"interaction":[21],"cells":[24],"with":[25,117,152,160],"their":[26],"microenvironment":[27],"play":[29],"important":[30],"roles":[31],"in":[32,54,85,89,100,115,137,150,155,185,194,200,204],"glioma":[33,209],"biology,":[34],"including":[35,69],"migration,":[36],"invasion,":[37],"angiogenesis":[38],"stem":[41],"anchorage.":[43],"Here,":[44],"we":[45],"review":[46],"preclinical":[47],"clinical":[49,87,148],"data":[50],"on":[51],"integrin":[52,64],"inhibition":[53],"malignant":[55],"gliomas.":[56],"Various":[57],"pharmacological":[58],"approaches":[59],"to":[60,105,109,181],"modulation":[62],"signaling":[65],"have":[66],"been":[67],"explored":[68],"antibodies":[70],"peptide-based":[72],"agents.":[73,221],"Cilengitide,":[74],"cyclic":[76],"RGD-mimetic":[77],"peptide":[78],"\u03b1v\u03b23":[80],"\u03b1v\u03b25":[82],"integrins":[83,205],"advanced":[86],"development":[88,214],"glioblastoma.":[90],"Cilengitide":[91],"had":[92],"only":[93],"limited":[94],"activity":[95],"as":[96,206],"single":[98],"agent":[99],"glioblastoma,":[101],"but,":[102],"when":[103],"added":[104,180],"standard":[106,153],"radiochemotherapy,":[107],"appeared":[108],"prolong":[110],"progression-free":[111],"overall":[113],"survival":[114],"patients":[116,159,186],"newly":[118,156],"diagnosed":[119,157],"glioblastomas":[120],"methylation":[122,136,164],"promoter":[125,135,163,190],"O\u2076":[128],"methylguanine":[129],"methyltransferase":[130],"(MGMT)":[131],"gene.":[132],"MGMT":[133,161,188],"gene":[134,162,189],"turn":[138],"predicts":[139],"benefit":[140],"from":[141],"alkylating":[142],"chemotherapy.":[143],"A":[144,171],"phase":[145],"III":[146],"randomized":[147],"trial":[149,173],"conjunction":[151],"radiochemotherapy":[154],"glioblastoma":[158],"has":[165],"recently":[166],"completed":[167],"accrual":[168],"(EORTC":[169],"26071-22072).":[170],"companion":[172],"explores":[174],"dose-escalated":[176],"regimen":[177],"cilengitide":[179],"radiotherapy":[182],"plus":[183],"temozolomide":[184],"without":[187],"methylation.":[191],"Promising":[192],"results":[193],"these":[195],"trials":[196],"would":[197],"probably":[198],"result":[199],"broader":[202,217],"interest":[203],"targets":[207],"therapy":[210],"hopefully":[212],"panel":[218],"anti-integrin":[220]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}